Home
/
WINDTREE THERAPEUTICS INC /DE/
/
Financials
/
Quarterly
WINDTREE THERAPEUTICS INC /DE/ — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that WINDTREE THERAPEUTICS INC /DE/ filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$198.0K
Nov 14, 2019
Q2
2019
Jun 30, 2019
$158.0K
Aug 14, 2019
Q1
2019
Mar 31, 2019
$40.0K
May 20, 2019
Q3
2019
Sep 30, 2018
$229.0K
Nov 14, 2019
Q2
2019
Jun 30, 2018
$1.05M
Aug 14, 2019
Q1
2019
Mar 31, 2018
$204.0K
May 20, 2019
Q3
2018
Sep 30, 2017
$17.0K
Nov 14, 2018
Q2
2018
Jun 30, 2017
$1.15M
Aug 14, 2018
Q1
2018
Mar 31, 2017
$219.0K
May 21, 2018
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Sep 30, 2016
$961.0K
Nov 14, 2016
Q2
2016
Jun 30, 2016
$106.0K
Aug 10, 2016
Q1
2016
Mar 31, 2016
$75.0K
May 12, 2016
Q3
2016
Sep 30, 2015
$66.0K
Nov 14, 2016
Q2
2016
Jun 30, 2015
$75.0K
Aug 10, 2016
Q1
2016
Mar 31, 2015
$191.0K
May 12, 2016
Q3
2015
Sep 30, 2014
$527.0K
Nov 5, 2015
Q2
2015
Jun 30, 2014
$1.09M
Aug 10, 2015
Q1
2015
Mar 31, 2014
$31.0K
May 11, 2015
Q3
2014
Sep 30, 2013
$60.0K
Nov 7, 2014
Q2
2014
Jun 30, 2013
$182.0K
Aug 7, 2014
Q1
2014
Mar 31, 2013
$72.0K
May 12, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($28.09M)
Nov 19, 2025
Q2
2025
Jun 30, 2025
($10.63M)
Aug 19, 2025
Q3
2025
Jun 30, 2025
($10.63M)
Nov 19, 2025
Q1
2025
Mar 31, 2025
($4.05M)
May 15, 2025
Q2
2025
Mar 31, 2025
($4.05M)
Aug 19, 2025
Q3
2025
Mar 31, 2025
($4.05M)
Nov 19, 2025
Q3
2025
Sep 30, 2024
($2.75M)
Nov 19, 2025
Q2
2025
Jun 30, 2024
($12.02M)
Aug 19, 2025
Q3
2025
Jun 30, 2024
($12.02M)
Nov 19, 2025
Q2
2025
Mar 31, 2024
$10.22M
Aug 19, 2025
Q1
2025
Mar 31, 2024
$10.22M
May 15, 2025
Q3
2025
Mar 31, 2024
$10.22M
Nov 19, 2025
Q3
2024
Sep 30, 2023
($4.43M)
Nov 26, 2024
Q3
2024
Jun 30, 2023
($6.60M)
Nov 26, 2024
Q2
2024
Jun 30, 2023
($6.60M)
Aug 19, 2024
Q2
2024
Mar 31, 2023
($4.11M)
Aug 19, 2024
Q1
2024
Mar 31, 2023
($4.11M)
May 15, 2024
Q3
2024
Mar 31, 2023
($4.11M)
Nov 26, 2024
Q3
2023
Sep 30, 2022
($4.06M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($17.33M)
Aug 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($19.88M)
Nov 19, 2025
Q2
2025
Jun 30, 2025
($3.98M)
Aug 19, 2025
Q1
2025
Mar 31, 2025
($4.09M)
May 15, 2025
Q3
2025
Sep 30, 2024
($4.74M)
Nov 19, 2025
Q2
2025
Jun 30, 2024
($11.45M)
Aug 19, 2025
Q1
2025
Mar 31, 2024
($4.41M)
May 15, 2025
Q3
2024
Sep 30, 2023
($4.69M)
Nov 26, 2024
Q2
2024
Jun 30, 2023
($6.76M)
Aug 19, 2024
Q1
2024
Mar 31, 2023
($4.19M)
May 15, 2024
Q3
2023
Sep 30, 2022
($4.65M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($17.54M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($8.33M)
May 15, 2023
Q3
2022
Sep 30, 2021
($8.15M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($45.36M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($9.08M)
May 5, 2022
Q3
2021
Sep 30, 2020
($8.71M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($7.95M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($6.70M)
May 13, 2021
Q3
2020
Sep 30, 2019
($7.19M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($6.50M)
Aug 14, 2020